KCM
AGIO icon

Kodai Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Kodai Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.49M Buy
+50,692
New +$1.68M 0.06% 130

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kodai Capital Management's AGIO Position: Q1 2025 in Review

Kodai Capital Management opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2025: 50,692 shares worth $1.49M. The stake represents 0.06% of the portfolio and ranks #130 among its holdings.

220 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • Kodai Capital Management held 50,692 shares of Agios Pharmaceuticals worth $1.49M as of Q1 2025.
  • Agios Pharmaceuticals was a new Kodai Capital Management position in Q1 2025.
  • Agios Pharmaceuticals made up 0.06% of Kodai Capital Management's portfolio in Q1 2025, its #130 holding.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on Kodai Capital Management's 13F filing for Q1 2025, filed 15 May 2025.